Shanghai Shenqi Pharmaceutical Investment Management Co 600613.SS · CNY
Health Care · Shanghai · 🇨🇳 China
6.51
+1.72%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shanghai Shenqi Pharmaceutical Investment Management Co
Its shares trade on Shanghai under the ticker 600613.SS. It has been listed since 20 August 1992. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.95bn and net income of CN¥38.2m. At that date it held total assets of CN¥3.15bn and shareholders' equity of CN¥2.32bn.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. The company is headquartered in Shanghai, Shanghai. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The firm's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The firm distributes its products in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 20 Aug 1992
- Employees
- 1,371
- Website
- gzsq.com ↗
Leadership
Pay as last reported
- Mr. Zhiting ZhangChairman of the Board, since 2020CN¥120,300
- Mr. Taotao ZhangVice Chairman of the Board, since 2006CN¥497,300
- Mr. Famiao LiChief Financial OfficerCN¥256,800
- Mr. Bin FengGeneral Manager, DirectorCN¥451,700
- Mr. Kejing WuSecretary of the Board, Director, since 2017CN¥416,400
- Ms. Tao WuDirectorCN¥24,000
- Ms. Dan XuDirectorCN¥24,000
- Mr. Shigui ChenIndependent DirectorCN¥60,000
- Ms. Congyan LiIndependent DirectorCN¥60,000
- Ms. Ning ZhouIndependent DirectorCN¥60,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shanghai Shenqi Pharmaceutical Investment Management Co Ltd operates in the Health Care sector within the Pharmaceuticals industry.
- The company employs 1371 staff members to support its operations.
- It distributes its products in the domestic market of China.
Weaknesses
- The company is headquartered in a single city, Shanghai.
- Its product portfolio is limited to specific therapeutic areas such as antitumor and cardiovascular drugs.
- The firm relies on a narrow range of main products including cantharidin sodium vitamin B6 injection.
Opportunities
- The company engages in the research and development of new pharmaceuticals.
- It manufactures and sells anti fungi drugs to expand its treatment offerings.
- The firm produces children medicine to address pediatric health needs.
Threats
- The company is listed on the Shanghai Stock Exchange with ticker 600613.SS.
- Its website is http://www.gzsq.com/, which may cause brand confusion.
- The firm faces competition in the oncology and gynaecology treatment segments.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.